Group One Trading’s Milestone Pharmaceuticals MIST Stock Holding History

Group One Trading’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$154K	Sell	129,764 -65,335	-33%	-$114K	﹤0.01%	4343
2025 Q4	$394K	Buy	195,099 +188,077	+2,678%	+$405K	﹤0.01%	3753
2025 Q3	$14K	Sell	7,022 -24,594	-78%	-$43.2K	﹤0.01%	6955
2025 Q2	$61.3K	Sell	31,616 -106,744	-77%	-$142K	﹤0.01%	5406
2025 Q1	$111K	Buy	138,360 +85,723	+163%	+$170K	﹤0.01%	4520
2024 Q4	$124K	Buy	+52,637	New	+$90.4K	﹤0.01%	4333
2024 Q1	–	Sell	-20,762	Closed	-$33.7K	–	7613
2023 Q4	$34.7K	Buy	+20,762	New	+$56.4K	﹤0.01%	5338
2023 Q2	–	Sell	-242	Closed	-$953	–	7991
2023 Q1	$953	Sell	242 -30,385	-99%	-$111K	﹤0.01%	6797
2022 Q4	$121K	Buy	30,627 +26,379	+621%	+$139K	﹤0.01%	4265
2022 Q3	$39K	Buy	+4,248	New	+$32.2K	﹤0.01%	5595

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Group One Trading's MIST Position: Q1 2026 in Review

Group One Trading reduced its Milestone Pharmaceuticals (MIST) stake by 33% in Q1 2026, selling an estimated $114K and leaving 129,764 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #4343.

Group One Trading first reported a position in MIST in Q3 2022 and has held it in 10 quarters since. The position peaked at $394K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

Group One Trading held 129,764 shares of Milestone Pharmaceuticals worth $154K as of Q1 2026.
Group One Trading sold 65,335 Milestone Pharmaceuticals shares in Q1 2026, an estimated $114K.
Milestone Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4343 holding.
Group One Trading first reported a position in Milestone Pharmaceuticals in Q3 2022 and has held it in 10 quarters since.
Group One Trading's Milestone Pharmaceuticals position peaked at $394K in Q4 2025.
86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.